Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke

Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke

Ischemic stroke (IS) refers to local brain tissue necrosis which is caused by impaired blood supply to the carotid artery or vertebrobasilar artery system. As the second leading cause of death in the world, IS has a high incidence and brings a heavy economic burden to all countries and regions becau...

Full description

Bibliographic Details
Main Authors:	Yongyi Zhan, Yue Dai, Zhejing Ding, Mingtian Lu, Zehua He, Zhengwei Chen, Yongkang Liu, Zhongliang Li, Guangsen Cheng, Shaojun Peng, Yu Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	ischemic stroke stimuli-responsive nanomedicine micro-environment drug delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2023.1329959/full

Similar Items

Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy
by: Yijun Zhao, et al.
Published: (2021-11-01)

Stimuli-responsive prodrug-based cancer nanomedicine
by: Angel Xie, et al.
Published: (2020-06-01)

Stimuli-Responsive Nanomaterials for Application in Antitumor Therapy and Drug Delivery
by: Son H. Pham, et al.
Published: (2020-07-01)

Recent advances in nanomedicines for the treatment of ischemic stroke
by: Chao Li, et al.
Published: (2021-07-01)

Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy
by: Su Yuanzhen, et al.
Published: (2023-02-01)

Single-, Dual-, and Multi-Stimuli-Responsive Nanogels for Biomedical Applications
by: Naveen Kumar, et al.
Published: (2024-01-01)

Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy
by: Zhang, Yijing, et al.
Published: (2023)

Stimuli‐responsive crosslinked nanomedicine for cancer treatment
by: Xiangdong Xue, et al.
Published: (2022-12-01)

A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug
by: Hao Cai, et al.
Published: (2020-03-01)

Nanomedicine for Ischemic Stroke
by: Xinyue Dong, et al.
Published: (2020-10-01)

The application of nanomedicine in clinical settings
by: Qingsong Zhao, et al.
Published: (2023-06-01)

Stimuli-responsive chitosan-based nanocarriers for cancer therapy
by: Marziyeh Fathi, et al.
Published: (2017-09-01)

Smart Vitamin Micelles as Cancer Nanomedicines for Enhanced Intracellular Delivery of Doxorubicin
by: Na Re Ko, et al.
Published: (2021-10-01)

Novel gas‐based nanomedicines for cancer therapy
by: Xianxian Yao, et al.
Published: (2022-01-01)

Nanomedicine and drug delivery /
by: Sebastian, Mathew, et al.
Published: (c201)

Nanomedicine in drug delivery /
by: Kumar, Arun, editor, et al.
Published: (c201)

Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
by: Di Chang, et al.
Published: (2021-06-01)

Role of macrophage in nanomedicine-based disease treatment
by: Siwei Song, et al.
Published: (2021-01-01)

Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
by: Sabya Sachi Das, et al.
Published: (2020-06-01)

Bioresponsive Polymers for Nanomedicine—Expectations and Reality!
by: Sabina Quader, et al.
Published: (2022-09-01)

Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms
by: Yuzhe Sun, et al.
Published: (2021-03-01)

Artificial exosomes for translational nanomedicine
by: Yong-Jiang Li, et al.
Published: (2021-08-01)

Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
by: Shaojun Peng, et al.
Published: (2022-01-01)

New Approaches in Nanomedicine for Ischemic Stroke
by: Clara Correa-Paz, et al.
Published: (2021-05-01)

Responsive Supramolecular Polymers for Diagnosis and Treatment
by: Mónica Martínez-Orts, et al.
Published: (2024-04-01)

Editorial: Microenvironmental stimuli-responsive nanomedicine for biomedical application
by: Donglin Xia, et al.
Published: (2023-05-01)

Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine
by: Rui Sun, et al.
Published: (2022-04-01)

Nanomedicine /
by: Hutto, Madelynn, author 647998
Published: (2012)

Advances in nanomedicines for lymphatic imaging and therapy
by: Pan He, et al.
Published: (2023-08-01)

Promising Nanomedicines of Shikonin for Cancer Therapy
by: Yan C, et al.
Published: (2023-03-01)

Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment
by: Hao Cai, et al.
Published: (2021-02-01)

Stimuli-Responsive Polymeric Nanosystems for Controlled Drug Delivery
by: Zhichu Xiang, et al.
Published: (2021-10-01)

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
by: Manman Xu, et al.
Published: (2023-06-01)

Development of Pharmaceutical Nanomedicines: From the Bench to the Market
by: Abdulrahman A. Halwani
Published: (2022-01-01)

Nanomedicine in Lung Cancer Immunotherapy
by: Mohammad Doroudian, et al.
Published: (2023-03-01)

Editorial: Advances and Challenges in Nanomedicine
by: Susan Hua, et al.
Published: (2018-11-01)

Moving beyond traditional therapies: the role of nanomedicines in lung cancer
by: Jingjing Zhang, et al.
Published: (2024-02-01)

Advances in Nanomedicines for Interaction with the Intestinal Barrier
by: Sisi Lin, et al.
Published: (2022-06-01)

Modelling tenofovir release kinetics from hyaluronidase-sensitive nanomedicine: A deterministic approach
by: Coulibaly S. Fohona, et al.
Published: (2023-09-01)

Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
by: Lucas Fornari Laurindo, et al.
Published: (2023-01-01)